SG Americas Securities’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-435,741
| Closed | -$37M | – | 3813 |
|
|
2019
Q4 | $37M | Buy |
435,741
+425,563
| +4,181% | +$28.4M | 0.34% | 47 |
|
|
2019
Q3 | $509K | Buy |
10,178
+6,532
| +179% | +$261K | ﹤0.01% | 1876 |
|
|
2019
Q2 | $133K | Sell |
3,646
-45,191
| -93% | -$1.48M | ﹤0.01% | 2658 |
|
|
2019
Q1 | $1.36M | Buy |
48,837
+34,313
| +236% | +$809K | 0.01% | 1091 |
|
|
2018
Q4 | $278K | Buy |
14,524
+3,234
| +29% | +$75.2K | ﹤0.01% | 2225 |
|
|
2018
Q3 | $338K | Sell |
11,290
-1,172
| -9% | -$44.2K | ﹤0.01% | 2310 |
|
|
2018
Q2 | $457K | Buy |
12,462
+7,362
| +144% | +$239K | ﹤0.01% | 2067 |
|
|
2018
Q1 | $168K | Sell |
5,100
-2,045
| -29% | -$63.9K | ﹤0.01% | 2549 |
|
|
2017
Q4 | $195K | Buy |
7,145
+1,805
| +34% | +$55.6K | ﹤0.01% | 2454 |
|
|
2017
Q3 | $198K | Buy |
+5,340
| New | +$197K | ﹤0.01% | 2595 |
|
|
2017
Q2 | – | Sell |
-2,305
| Closed | -$113K | – | 3668 |
|
|
2017
Q1 | $113K | Sell |
2,305
-65,900
| -97% | -$3.01M | ﹤0.01% | 2902 |
|
|
2016
Q4 | $2.31M | Buy |
68,205
+20,508
| +43% | +$727K | 0.02% | 834 |
|
|
2016
Q3 | $1.8M | Buy |
47,697
+19,538
| +69% | +$736K | 0.02% | 799 |
|
|
2016
Q2 | $947K | Sell |
28,159
-8,203
| -23% | -$289K | 0.01% | 1334 |
|
|
2016
Q1 | $1.16M | Buy |
36,362
+4,995
| +16% | +$163K | 0.01% | 1219 |
|
|
2015
Q4 | $1.17M | Buy |
31,367
+17,010
| +118% | +$643K | 0.01% | 1037 |
|
|
2015
Q3 | $545K | Sell |
14,357
-27,926
| -66% | -$980K | ﹤0.01% | 1037 |
|
|
2015
Q2 | $1.21M | Buy |
+42,283
| New | +$1.18M | 0.01% | 978 |
|
|
2015
Q1 | – | Sell |
-22,992
| Closed | -$636K | – | 3241 |
|
|
2014
Q4 | $636K | Buy |
22,992
+13,823
| +151% | +$342K | ﹤0.01% | 1494 |
|
|
2014
Q3 | $205K | Buy |
+9,169
| New | +$233K | ﹤0.01% | 1979 |
|
|
2014
Q2 | – | Sell |
-58,841
| Closed | -$1.67M | – | 2786 |
|
|
2014
Q1 | $1.67M | Buy |
58,841
+46,640
| +382% | +$1.54M | 0.01% | 952 |
|
|
2013
Q4 | $471K | Sell |
12,201
-8,858
| -42% | -$317K | ﹤0.01% | 1590 |
|
|
2013
Q3 | $706K | Buy |
21,059
+7,649
| +57% | +$244K | ﹤0.01% | 1432 |
|
|
2013
Q2 | $412K | Buy |
+13,410
| New | +$449K | ﹤0.01% | 1342 |
|
Other funds holding MDCO
SG Americas Securities's MDCO Position: Q1 2020 in Review
SG Americas Securities sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 435,741 shares — an estimated $37M sold.
SG Americas Securities first reported a position in MDCO in Q2 2013 and held it in 24 quarters. The position peaked at $37M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- SG Americas Securities reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- SG Americas Securities sold 435,741 Medicines Co shares in Q1 2020, an estimated $37M.
- SG Americas Securities first reported a position in Medicines Co in Q2 2013 and held it in 24 quarters.
- SG Americas Securities's Medicines Co position peaked at $37M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on SG Americas Securities's 13F filing for Q1 2020, filed 30 Apr 2020.